Loading...
Loading...
India's ofloxacin imports from UNITED STATES total $639.9K across 109 shipments from 15 foreign suppliers. PAR STERILE PRODUCTS leads with $116.8K in import value; the top 5 suppliers together control 61.0% of this origin. Leading Indian buyers include INDOCO REMEDIES LIMITED. This corridor reflects India's pharmaceutical import demand for ofloxacin โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

PAR STERILE PRODUCTS is the leading Ofloxacin supplier from UNITED STATES to India, with import value of $116.8K across 2 shipments. The top 5 suppliers โ PAR STERILE PRODUCTS, MACLEODS PHARMA USA INC, ESPEE BIOPHARMA & FINECHEM LLC, AGRACE PHARMA., BILCARE GCS INC. โ collectively account for 61.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR STERILE PRODUCTS | $116.8K | 2 | 18.2% |
| 2 |
| MACLEODS PHARMA USA INC |
| $81.2K |
| 1 |
| 12.7% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $71.2K | 3 | 11.1% |
| 4 | AGRACE PHARMA. | $70.8K | 3 | 11.1% |
| 5 | BILCARE GCS INC. | $50.6K | 6 | 7.9% |
| 6 | AMSTERDAM PHARMA(APTEKA RX INC.) | $48.2K | 5 | 7.5% |
| 7 | AMSTERDAM PHARMA(APTEKA RX INC) | $35.5K | 2 | 5.5% |
| 8 | ESPEE BIOPHARMA & FINECHEM LLC. | $31.2K | 2 | 4.9% |
| 9 | PHARMAQUELLE LLC | $17.8K | 1 | 2.8% |
| 10 | AMSTERDAM PHARMA | $16.5K | 2 | 2.6% |
| 11 | REGIONAL PHARMACY | $14.6K | 5 | 2.3% |
| 12 | RAFF & HALL PHARMACY | $13.4K | 3 | 2.1% |
| 13 | NEWLIFE MEDICALS (USA). INC. | $9.2K | 4 | 1.4% |
| 14 | AGRACE PHARMA | $7.5K | 7 | 1.2% |
| 15 | Espee Biopharma & Finechem LLC | $6.9K | 2 | 1.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INDOCO REMEDIES LIMITED | $124.4K | 10 | 19.4% |
| 2 | PAR FORMULATIONS PRIVATE LIMITED | $116.8K | 2 | 18.2% |
| 3 | MACLEODS PHARMACEUTICALS LTD | $81.2K | 1 | 12.7% |
| 4 | AUROBINDO PHARMA LTD | $77.0K | 11 | 12.0% |
| 5 | MICRO LABS LIMITED | $55.4K | 4 | 8.7% |
| 6 | MANKIND PHARMA LIMITED | $53.2K | 10 | 8.3% |
| 7 | DR.REDDY'S LABORATORIES LTD | $48.4K | 5 | 7.6% |
| 8 | AUROBINDO PHARMA LIMITED | $19.9K | 7 | 3.1% |
| 9 | MANKIND PHARMA LTD | $16.5K | 2 | 2.6% |
| 10 | FDC LIMITED | $13.9K | 4 | 2.2% |
| 11 | CAPLIN STERILES LIMITED | $7.4K | 3 | 1.2% |
| 12 | HETERO LABS LIMITED | $4.7K | 4 | 0.7% |
| 13 | GLAND PHARMA LTD | $4.6K | 1 | 0.7% |
| 14 | HETERO LABS LIMITED | $4.1K | 2 | 0.6% |
| 15 | DR REDDY S LABORATORIES LIMITED | $3.8K | 2 | 0.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ofloxacin suppliers from UNITED STATES to India include PAR STERILE PRODUCTS, MACLEODS PHARMA USA INC, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is PAR STERILE PRODUCTS with import value of $116.8K USD across 2 shipments. India imported Ofloxacin worth $639.9K USD from UNITED STATES in total across 109 shipments.
India imported Ofloxacin worth $639.9K USD from UNITED STATES across 109 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ofloxacin sourced from UNITED STATES include INDOCO REMEDIES LIMITED, PAR FORMULATIONS PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD. The largest buyer is INDOCO REMEDIES LIMITED with $124.4K in imports across 10 shipments.
The total value of Ofloxacin imports from UNITED STATES to India is $639.9K USD, across 109 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
109 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists